Results
3
Companies which are more than 50% undervalued based on analyst price target.
3 companies
Nyxoah
Market Cap: €240.7m
A medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA).
NYXH
€6.43
7D
-8.5%
1Y
-23.1%
Onward Medical
Market Cap: €192.0m
A medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI).
ONWD
€4.30
7D
-8.8%
1Y
-18.3%
Sequana Medical
Market Cap: €51.2m
Develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally.
SEQUA
€0.94
7D
-6.1%
1Y
-36.3%